Dog — Dog (other) — MSK
FDA Report #N141585 — September 18, 2025
Animal Information
| Species | Dog |
| Breed | Dog (other) |
| Gender | Male |
| Age | 13.41 Year |
| Weight | 16.330 Kilogram |
Drug Information
| Brand Name | MSK |
| Active Ingredients | Ilunocitinib |
| Manufacturer | MSK |
Reactions
Pale mucous membrane; Weakness; Ataxia; Elevated creatinine; Tachycardia; Decreased haematocrit; Disorder of red blood cell NOS; Decreased mean corpuscular haemoglobin concentration (MCHC); Lack of efficacy - NOS; Shallow breathing; Low platelet count; Decreased haemoglobin; Elevated blood urea nitrogen (BUN); Lymphopenia; Decreased red blood cell count; Hyperglycaemia; Abnormal radiograph finding; Neutrophilia; Vomiting bile; Lethargy (see also Central nervous system depression in Neurological)
Outcome
Ongoing
Onset Date
September 18, 2025